The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406
Estimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis
Sandrin, L., Fourquet, B., Hasquenoph, J.-M., Yon, S., Fournier, C., Mal, F., Christidis, C., Ziol, M., Poulet, B., Kazemi, F., et al. (2003) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2003.07.001 · Cited by 2,738
Global Burden of Disease and Risk Factors
(2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,605
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,569
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bedossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,376
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Regev, A., Berho, M. E., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N., Feng, Z.-Z., Reddy, K. R., & Schiff, E. R. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04396-4 · Cited by 2,093
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Panahi, M., Naderi, M., Morteza, T. S., & Parizadeh, S. M. J. (2007) · Cited by 1,722
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
Ziol, M., Handra-Luca, A., Kettaneh, A., Christidis, C., Mal, F., Kazemi, F., de Lédinghen, V., Marcellin, P., Dhumeaux, D., Trinchet, J.-C., et al. (2005) · Hepatology · doi:10.1002/hep.20506 · Cited by 1,470
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., & Poynard, T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04258-6 · Cited by 1,433
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150
Poynard, T., McHutchison, J., Manns, M., Trepo, C., Lindsay, K., Goodman, Z., Ling, M., & Albrecht, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.33023 · Cited by 1,146
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B
Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T.-T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z., Wulfsohn, M. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021812 · Cited by 995
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Hepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 954
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Fraquelli, M., Rigamonti, C., Casazza, G., Conte, D., Donato, M. F., Ronchi, G., & Colombo, M. (2007) · Gut · doi:10.1136/gut.2006.111302 · Cited by 854
Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
Zeisberg, M., Yang, C., Martino, M., Duncan, M. B., Rieder, F., Tanjore, H., & Kalluri, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700194200 · Cited by 839
Global burden of disease and risk factors
(2007) · Choice Reviews Online · doi:10.5860/choice.44-4479 · Cited by 825
Akriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., & Shakil, O. (2000) · Gastroenterology · doi:10.1053/gast.2000.20189 · Cited by 800
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi206 · Cited by 743
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial
Lindor, K. D., Kowdley, K. V., Heathcote, J. E., Harrison, E. M., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., & Colin, P. (2004) · Hepatology · doi:10.1002/hep.20092 · Cited by 727
Deaths: preliminary data for 2002.
Kochanek, K. D., & Smith, B. L. (2004) · PubMed · Cited by 700
Deaths: Preliminary Data for 2001: (566622006-001)
Arias, E., & Smith, B. L. (2003) · PsycEXTRA Dataset · doi:10.1037/e566622006-001 · Cited by 661
Marrero, J. A., Fontana, R. J., Su, G. L., Conjeevaram, H. S., Emick, D. M., & Lok, A. S. (2002) · Hepatology · doi:10.1002/hep.1840360609 · Cited by 660
Sato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., Matsunaga, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1396 · Cited by 609
Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1053/gast.2003.50004 · Cited by 596
The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
Mathers, C. D., López, A. D., & Murray, C. J. L. (2006) · Cited by 591
Burden of liver disease in the United States: Summary of a workshop
Kim, R. W., Brown, R. S., Terrault, N. A., & El-Serag, H. (2002) · Hepatology · doi:10.1053/jhep.2002.34734 · Cited by 589
Yim, H. J., & Lok, A. S.-F. (2006) · Hepatology · doi:10.1002/hep.20956 · Cited by 545
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Armstrong, G. L., Alter, M. J., McQuillan, G. M., & Margolis, H. S. (2000) · Hepatology · doi:10.1002/hep.510310332 · Cited by 523
Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver
Ferenci, P., Dragosics, B., Dittrich, H., Frank, H., Benda, L., Lochs, H., Meryn, S., Base, W., & Schneider, B. (1989) · Journal of Hepatology · doi:10.1016/0168-8278(89)90083-4 · Cited by 496
The Bone Marrow Functionally Contributes to Liver Fibrosis
Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F., Bou–Gharios, G., Jeffery, R., Iredale, J. P., & Forbes, S. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.036 · Cited by 483
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A., & Border, W. A. (1996) · Nature Medicine · doi:10.1038/nm0496-418 · Cited by 482
Wong, V. W., Reesink, H., Ip, H. H., Nco Lelie, P., Reerink-Brongers, E., Yeung, C. Y., & Ma, H. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92388-2 · Cited by 480
Corpechot, C., Barbu, V., Wendum, D., Kinnman, N., Rey, C., Poupon, R., Housset, C., & Rosmorduc, O. (2002) · Hepatology · doi:10.1053/jhep.2002.32524 · Cited by 480
Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis
Arthur, M. J. P. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.2.g245 · Cited by 478
Peroxisome proliferator-activated receptors and hepatic stellate cell activation
Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H. F., Motomura, K., Anania, F. A., Willson, T. M., & Tsukamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006577200 · Cited by 473
Fiorucci, S., Antonelli, E., Rizzo, G., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pellicciari, R., & Morelli, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.001 · Cited by 472
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis
Kisseleva, T., Uchinami, H., Feirt, N., Quintana-Bustamante, O., Segovia, J. C., Schwabe, R. F., & Brenner, D. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.04.014 · Cited by 469
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
Ratziu, V., Bonyhay, L., Di Martino, V., Charlotte, F., Cavallaro, L., Sayegh-Tainturier, M.-H., Giral, P., Grimaldi, A., Opolon, P., & Poynard, T. (2002) · Hepatology · doi:10.1053/jhep.2002.33324 · Cited by 464
Mato, J. M., Cámara, J., Paz, J. F. D., Caballería, L., Coll, S., Caballero, A., García-Buey, L., Beltrán, J., Benita, V., Caballería, J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80263-3 · Cited by 463
Sebus, J., Er, C., & Ja, V. D. B. (1964) · PubMed · Cited by 463
Epidemiology and Natural History of NAFLD and NASH
Ong, J. P., & Younossi, Z. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.009 · Cited by 457
Kojima, S.-I., Watanabe, N., Numata, M., Ogawa, T., & Matsuzaki, S. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1178-8 · Cited by 455
Jarnagin, W. R., Rockey, D. C., Koteliansky, V. E., Wang, S. S., & Bissell, D. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2037 · Cited by 452
Hammel, P., Couvelard, A., O'Toole, D., Ratouis, A., Sauvanet, A., Fléjou, J. F., Degott, C., Belghiti, J., Bernades, P., Valla, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440604 · Cited by 427
Global programme for control of hepatitis B infection
Kane, M. (1995) · Vaccine · doi:10.1016/0264-410x(95)80050-n · Cited by 427
Maher, J. J., & McGuire, R. F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114886 · Cited by 423
Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics
Callewaert, N., Vlierberghe, H. V., Hecke, A. V., Laroy, W., Delanghe, J., & Contreras, R. (2004) · Nature Medicine · doi:10.1038/nm1006 · Cited by 418
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
Liu, Y., Binz, J., Numerick, M. J., Dennis, S., Luo, G., Desai, B., MacKenzie, K. I., Mansfield, T. A., Kliewer, S. A., Goodwin, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18945 · Cited by 398
Obesity and hepatocellular carcinoma
Caldwell, S. H., Crespo, D. M., Kang, H. S., & Al-Osaimi, A. M. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.021 · Cited by 396
A Randomized Trial of Prednisolone in Patients with Severe Alcoholic Hepatitis
Ramond, M.-J., Poynard, T., Rueff, B., Mathurin, P., Théodore, C., Chaput, J.-C., & Benhamou, J.-P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260802 · Cited by 392
American Gastroenterological Association Technical Review on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.010 · Cited by 384
McQuillan, G. M., Coleman, P. J., Kruszon-Moran, D., Moyer, L. A., Lambert, S. B., & Margolis, H. S. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.1.14 · Cited by 376
Wright, M. C., Issa, R., Smart, D. E., Trim, N., Murray, G. I., Primrose, J. N., Arthur, M. J. P., Iredale, J. P., & Mann, D. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.27188 · Cited by 356
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
Benyon, R., Iredale, J., Goddard, S., Winwood, P., & Arthur, M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608892 · Cited by 353
Bataller, R., Sancho-bru, P., Ginès, P., Lora, J. M., Al-garawi, A., Solé, M., Colmenero, J., Nicolás, J. M., Jiménez, W., Weich, N., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00695-4 · Cited by 352
Noninvasive Measures of Liver Fibrosis
Rockey, D. C., & Bissell, M. D. (2006) · Hepatology · doi:10.1002/hep.21046 · Cited by 349
Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture.
Rockey, D. C., Boyles, J. K., Gabbiani, G., & Friedman, S. L. (1992) · PubMed · Cited by 342
Epidemiology of hepatitis B in Europe and worldwide
Alter, M. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00141-7 · Cited by 338
Liver and Intestine Transplantation in the United States, 1997–2006
Freeman, R. B., Steffick, D. E., Guidinger, M. K., Farmer, D. G., Berg, C. L., & Merion, R. M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02174.x · Cited by 333
Parés, A., Planas, R., Torres, M., Caballería, J., Viver, J. M., Acero, D., Panés, J., Rigau, J., Santos, J., & Rodés, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80285-7 · Cited by 331
Severe Liver Fibrosis or Cirrhosis: Accuracy of US for Detection—Analysis of 300 Cases
Colli, A., Fraquelli, M., Andreoletti, M., Marino, B., Zuccoli, E., & Conte, D. (2003) · Radiology · doi:10.1148/radiol.2272020193 · Cited by 330
Colchicine in the Treatment of Cirrhosis of the Liver
Kershenobich, D., Vargas, F., Garcia-Tsao, G., Tamayo, R. P., Gent, M., & Rojkind, M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182602 · Cited by 328
Epidemiology of Hepatocellular Carcinoma
El-Serag, H. B. (2001) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70155-0 · Cited by 327
George, J., Roulot, D., Koteliansky, V. E., & Bissell, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12719 · Cited by 322
Hazra, S., Xiong, S., Wang, J., Rippe, R. A., Krishna, V., Chatterjee, K., & Tsukamoto, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310284200 · Cited by 320
Issa, R., Williams, E., Trim, N., Kendall, T., Arthur, M. J. P., Reichen, J., Benyon, R. C., & Iredale, J. P. (2001) · Gut · doi:10.1136/gut.48.4.548 · Cited by 319
Goulis, J., Leandro, G., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11293-x · Cited by 315
A Prospective Trial of Colchicine for Primary Biliary Cirrhosis
Kaplan, M. M., Alling, D. W., Zimmerman, H. J., Wolfe, H. J., Sepersky, R. A., Hirsch, G. S., Elta, G. H., Glick, K. A., & Eagen, K. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612043152304 · Cited by 313
Skelly, M. M., James, P. D., & Ryder, S. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00094-0 · Cited by 310
Oxidative mechanisms in the pathogenesis of alcoholic liver disease
Albano, E. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.004 · Cited by 302
Liver biopsy: complications and risk factors
Thampanitchawong, P. (2000) · World Journal of Gastroenterology · doi:10.3748/wjg.v5.i4.301 · Cited by 297
Boigk, G., Stroedter, L., Herbst, H., Waldschmidt, J., Riecken, E. O., & Schuppan, D. (1997) · Hepatology · doi:10.1002/hep.510260316 · Cited by 293
Daily Cannabis Smoking as a Risk Factor for Progression of Fibrosis in Chronic Hepatitis C *
Hézode, C., Roudot-Thoraval, F., Nguyen, S., Grenard, P., Julien, B., Zafrani, E.-S., Pawlostky, J.-M., Dhumeaux, D., Lotersztajn, S., & Mallat, A. (2005) · Hepatology · doi:10.1002/hep.20733 · Cited by 293
Blasco, A., Forns, X., Carrión, J. A., García-Pagán, J. C., Gilabert, R., Rimola, A., Miquel, R., Bruguera, M., García-Valdecasas, J.-C., Bosch, J., et al. (2006) · Hepatology · doi:10.1002/hep.21090 · Cited by 293
Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis
Dufour, J.-F., DeLellis, R., & Kaplan, M. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00006 · Cited by 290
The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans
El-Serag, H. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02617-x · Cited by 274
COMBES, B. (1995) · Hepatology · doi:10.1016/0270-9139(95)90294-5 · Cited by 268
Tugues, S., Fernandez-Varo, G., Muñoz-Luque, J., Ros, J., Arroyo, V., Rodés, J., Friedman, S. L., Carmeliet, P., Jiménez, W., & Morales-Ruiz, M. (2007) · Hepatology · doi:10.1002/hep.21921 · Cited by 261
Chevallier, M., Guerret, S., Chossegros, P., Gerard, F., & Grimaud, J.-A. (1994) · Hepatology · doi:10.1002/hep.1840200213 · Cited by 256
Non-alcoholic Steatohepatitis and Cancer
Bugianesi, E. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.006 · Cited by 245
Jacquemin, E., Hermans, D., Myara, A., Habes, D., Debray, D., Hadchouel, M., Sokal, E. M., & Bernard, O. (1997) · Hepatology · doi:10.1002/hep.510250303 · Cited by 245
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis†
Lutchman, G., Modi, A., Kleiner, D. E., Promrat, K., Heller, T., Ghany, M., Borg, B., Loomba, R., Liang, T. J., Premkumar, A., et al. (2007) · Hepatology · doi:10.1002/hep.21661 · Cited by 244
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200111000-00029 · Cited by 243
Interleukin–10 Expression and Function in Experimental Murine Liver Inflammation and Fibrosis
Thompson, K., Maltby, J., Fallowfield, J., McAulay, M., Millward-Sadler, H., & Sheron, N. (1998) · Hepatology · doi:10.1002/hep.510280620 · Cited by 236
Effects of Sho–Saiko–To, A Japanese Herbal Medicine, on Hepatic Fibrosis in Rats
Shimizu, I., Ma, Y.-R., Mizobuchi, Y., Liu, F., Miura, T., Nakai, Y., Yasuda, M., Shiba, M., Horie, T., Amagaya, S., et al. (1999) · Hepatology · doi:10.1002/hep.510290108 · Cited by 236
Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis
Tilg, H., Jalan, R., Kaser, A., Davies, N. A., Offner, F. A., Hodges, S. J., Ludwiczek, O., Shawcross, D., Zoller, H., Alisa, A., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00442-7 · Cited by 232
Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis
Hirose, A., Ono, M., Saibara, T., Nozaki, Y., Masuda, K., Yoshioka, A., Takahashi, M., Akisawa, N., Iwasaki, S., Oben, J. A., et al. (2007) · Hepatology · doi:10.1002/hep.21638 · Cited by 232
Worldwide mortality from cirrhosis: An update to 2002
Bosetti, C., Levi, F., Lucchini, F., Zatonski, W. A., Negri, E., & La Vecchia, C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.025 · Cited by 230
Changing trends in hepatitis C–related mortality in the United States, 1995‐2004†‡
Wise, M., Bialek, S., Finelli, L., Bell, B. P., & Sorvillo, F. (2008) · Hepatology · doi:10.1002/hep.22165 · Cited by 229
McHutchison, J. G., Blatt, L. M., De Medina, M., Craig, J. R., Conrad, A., Schiff, E. R., Tong, M. J., & Group, T. C. I. S. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02233.x · Cited by 229
Recommendations for protection against viral hepatitis
Drake, T. (1986) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(86)80596-0 · Cited by 228
Kinnman, N., Francoz, C., Barbu, V., Wendum, D., Rey, C., Hultcrantz, R., Poupon, R., & Housset, C. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000054178.01162.e4 · Cited by 222
Houglum, K., Venkataramani, A., Lyche, K., & Chojkier, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322499 · Cited by 219
Poupon, R. E., Lindor, K. D., Parés, A., Chazouillères, O., Poupon, R., & Heathcote, E. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00192-2 · Cited by 217
Spahr, L., Rubbia-Brandt, L., Frossard, J.-L., Giostra, E., Rougemont, A.-L., Pugin, J., Fischer, M., Egger, H., & Hadengue, A. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00230-1 · Cited by 214
Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis
Poupon, R. E., Bonnand, A.-M., Chrétien, Y., & Poupon, R. (1999) · Hepatology · doi:10.1002/hep.510290603 · Cited by 209
Pilette, C., Rousselet, M. C., Bedossa, P., Chappard, D., Oberti, F., Rifflet, H., Maïga, M. Y., Gallois, Y., & Calès, P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80318-8 · Cited by 205
Nelson, D. R., Tu, Z., Soldevila-Pico, C., Abdelmalek, M., Zhu, H., Xu, Y. L., Cabrera, R., Liu, C., & Davis, G. L. (2003) · Hepatology · doi:10.1002/hep.1840380412 · Cited by 202
Rockey, D. C., & Chung, J. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118925 · Cited by 199
Textbook of hepatology : from basic science to clinical practice
Rodés, J. (2007) · Cited by 192
Alexia, C., Fallot, G., Lasfer, M., Schweizer-Groyer, G., & Groyer, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.029 · Cited by 191
A randomized placebo controlled trial of vitamin E for alcoholic hepatitis
Mezey, E., Potter, J. J., Rennie-Tankersley, L., Caballeria, J., & Pares, A. (2004) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00476-8 · Cited by 184
DOUGLAS, W. W., RYU, J. H., SWENSEN, S. J., OFFORD, K. P., SCHROEDER, D. R., CARON, G. M., & DeREMEE, R. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9709089 · Cited by 182
Inhibition of Rat Hepatic Lipocyte Activation in Culture by Interferon–γ
Rockey, D. C., Maher, J. J., Jarnagin, W. R., Gabbiani, G., & Friedman, S. L. (1992) · Hepatology · doi:10.1002/hep.1840160325 · Cited by 179
Assessment of utilities and health-related quality of life in patients with chronic liver disease
Younossi, Z. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02330-3 · Cited by 178
Sakaida, I., Tsuchiya, M., Kawaguchi, K., Kimura, T., Terai, S., & Okita, K. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00094-1 · Cited by 176
Lindblad, A., Glaumann, H., & Strandvik, B. (1998) · Hepatology · doi:10.1002/hep.510270126 · Cited by 175
Degott, C., Zafrani, E. S., Callard, P., Balkau, B., Poupon, R. E., & Poupon, R. (1999) · Hepatology · doi:10.1002/hep.510290444 · Cited by 174
Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis
Siller-López, F., Sandoval, A., Salgado, S., Salazar, A., Bueno, M., Garcia, J., Vera, J., Gálvez, J., Hernández, I., & Ramos, M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.045 · Cited by 173
Pirfenidone effectively reverses experimental liver fibrosis
Garcı́a, L., Hernández, I., Sandoval, A., Salazar, A., Garcia, J., Vera, J., Grijalva, G., Muriel, P., Margolin, S., & Armendariz-Borunda, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00272-6 · Cited by 172
Vascular mediators in the injured liver
Rockey, D. C. (2003) · Hepatology · doi:10.1053/jhep.2003.50044 · Cited by 168
Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats
Takahara, T., Furui, K., Funaki, J., Nakayama, Y., Itoh, H., Miyabayashi, C., Sato, H., Seiki, M., Ooshima, A., & Watanabe, A. (1995) · Hepatology · doi:10.1002/hep.1840210328 · Cited by 168
Michael, R. P. (1966) · BMJ · doi:10.1136/bmj.1.5496.1174 · Cited by 166
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct–ligated rats†
Bataller, R., Gäbele, E., Parsons, C. J., Morris, T., Yang, L., Schoonhoven, R., Brenner, D. A., & Rippe, R. A. (2005) · Hepatology · doi:10.1002/hep.20665 · Cited by 166
González-Abraldes, J., Albillos, A., Bañares, R., Del Arbol, L. R., Moitinho, E., Rodríguez, C., González, M., Escorsell, A., García-Pagán, J. C., & Bosch, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26288 · Cited by 165
Trial of Penicillamine in Advanced Primary Biliary Cirrhosis
Dickson, E. R., Fleming, T. R., Wiesner, R. H., Baldus, W. P., Fleming, C. R., Ludwig, J., & McCall, J. T. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504183121602 · Cited by 165
Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography
Rockey, D. C. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.053 · Cited by 164
Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries
Ramstedt, M. (2001) · Addiction · doi:10.1046/j.1360-0443.96.1s1.2.x · Cited by 162
Pirfenidone improves renal function and fibrosis in the post-obstructed kidney
Shimizu, T., Kuroda, T., Hata, S., Fukagawa, M., Margolin, S. B., & Kurokawa, K. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00962.x · Cited by 161
Yata, Y., Gotwals, P., Koteliansky, V., & Rockey, D. C. (2002) · Hepatology · doi:10.1053/jhep.2002.32673 · Cited by 159
Williams, J. G., Roberts, S. E., Ali, M. F., Cheung, W. Y., Cohen, D. R., Demery, G., Edwards, A., Greer, M., Hellier, M. D., Hutchings, H. A., et al. (2007) · Gut · doi:10.1136/gut.2006.117598 · Cited by 158
Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons
Lieber, C. S., Leo, M. A., Cao, Q., Ren, C., & DeCarli, L. M. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200310000-00013 · Cited by 156
Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity
Seeff, L. B., & Hoofnagle, J. H. (2006) · Oncogene · doi:10.1038/sj.onc.1209560 · Cited by 155
Jia, J., Bauer, M. W., Cho, J. J., Ruehl, M., Milani, S., Boigk, G., Riecken, E. O., & Schuppan, D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00148-9 · Cited by 154
Differential effects of gamma-interferon on collagen and fibronectin gene expression.
Czaja, M. J., Weiner, F. R., Eghbali, M., Giambrone, M. A., Eghbali, M., & Zern, M. Α. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45207-6 · Cited by 152
Chronic liver disease mortality in the United States, 1990-1998
Vong, S., & Bell, B. P. (2004) · Hepatology · doi:10.1002/hep.20049 · Cited by 150
Beljaars, L., Molema, G., Schuppan, D., Geerts, A. E., Bleser, P. J. D., Weert, B., Meijer, D. K. F., & Poelstra, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12743 · Cited by 146
Aithal, G. P., Haugk, B., Das, S., Card, T. R., Burt, A. D., & Record, C. O. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2004.01819.x · Cited by 145
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-3-391 · Cited by 144
Schepke, M., Werner, E., Biecker, E., Schiedermaier, P., Heller, J., Neef, M., Caselmann, W. H., Sauerbruch, T., Stoffel‐Wagner, B., & Hofer, U. (2001) · Gastroenterology · doi:10.1053/gast.2001.26295 · Cited by 142
Treatment of chronic liver diseases with traditional Chinese medicine
Wang, B.-E. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02100.x · Cited by 138
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production
Di Sario, A., Bendia, E., Svegliati Baroni, G., Ridolfi, F., Casini, A., Ceni, E., Saccomanno, S., Marzioni, M., Trozzi, L., Sterpetti, P., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00245-3 · Cited by 138
Singh, G. K., & Hoyert, D. L. (2000) · PubMed · Cited by 138
Koca, S. S., Bahçecioğlu, İ. H., Poyrazoğlu, O. K., Özercan, İ. H., Şahin, K., & Üstündağ, B. (2007) · Inflammation · doi:10.1007/s10753-007-9053-z · Cited by 137
Luk, J. M., Wang, X., Liu, P., Wong, K., Chan, K., Tong, Y., Hui, C. K., Lau, G. K. K., & Fan, S. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01527.x · Cited by 136
Rockey, D. C., & Chung, J. J. (1994) · PubMed · Cited by 135
Préaux, A.-M., Mallat, A., Nhieu, J. T. V., d’Ortho, M., Hembry, R. M., & Mavier, P. (1999) · Hepatology · doi:10.1002/hep.510300432 · Cited by 134
Kaplan, M. M., DeLellis, R. A., & Wolfe, H. J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-9-199705010-00002 · Cited by 132
Wang, X., Kanel, G. C., & DeLeve, L. D. (2000) · Hepatology · doi:10.1002/hep.510310224 · Cited by 130
Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
Selman, M., Carrillo, G., Salas, J., Pérez‐Padilla, R., Pèrez-Chavira, R., Sansores, R., & Chapela, R. (1998) · CHEST Journal · doi:10.1378/chest.114.2.507 · Cited by 128
Aleynik, S. I., Leo, M. A., Ma, X., Aleynik, M. K., & LIEBER, C. S. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80361-3 · Cited by 128
A Pilot Study of the Safety and Tolerability of Etanercept in Patients with Alcoholic Hepatitis
Menon, K. V. N., Stadheim, L. M., Kamath, P. S., Wiesner, R. H., Gores, G. J., Peine, C. J., & Shah, V. H. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04034.x · Cited by 127
Antifibrotic therapy in chronic liver disease
Rockey, D. C. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00445-8 · Cited by 120
Cyclic Arg-Gly-Asp Peptide-Labeled Liposomes for Targeting Drug Therapy of Hepatic Fibrosis in Rats
Du, S.-L., Pan, H., Lu, W., Wang, J., Wu, J., & Wang, J.-Y. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.122481 · Cited by 120
Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis
Yang, L., Chan, C., Kwon, O.-S., Liu, S., McGhee, J., Stimpson, S. A., Chen, L. Z., Harrington, W. W., Symonds, W. T., & Rockey, D. C. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00124.2006 · Cited by 119
Hepatic fibrosis 2006: Report of the third AASLD Single Topic Conference
Friedman, S. L., Rockey, D. C., & Bissell, M. D. (2006) · Hepatology · doi:10.1002/hep.21459 · Cited by 117
O’Brien, M. J., Keating, N. M., Elderiny, S., Cerda, S. R., Keaveny, A. P., Afdhal, N. H., & Nunes, D. (2000) · American Journal of Clinical Pathology · doi:10.1309/d7au-eyw7-4b6c-k08y · Cited by 116
Autocrine release of TGF‐β by portal fibroblasts regulates cell growth
Wells, R. G., Kruglov, E. A., & Dranoff, J. A. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00037-7 · Cited by 114
Kerr, W. C., Fillmore, K. M., & Marvy, P. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9533394.x · Cited by 111
Pockros, P. J., Jeffers, L. J., Afdhal, N. H., Goodman, Z. D., Nelson, D. R., Gish, R. G., Reddy, K. R., Reindollar, R., Rodriguez‐Torres, M., Sullivan, S., et al. (2007) · Hepatology · doi:10.1002/hep.21561 · Cited by 111
Mortality and Hospital Utilization for Hepatocellular Carcinoma in the United States
Kim, W. R., Gores, G. J., BENSON, J., Therneau, T. M., & MELTONIII, L. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.001 · Cited by 106
Self-citationHendrickse, M. T., Rigney, E., Giaffer, M. H., Soomro, I. N., Triger, D. R., Underwood, J. C. E., & Gleeson, D. C. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900400 · Cited by 101
Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries
Ramstedt, M. (2001) · Addiction · doi:10.1080/09652140020021152 · Cited by 96
Limitations of conventionally derived chronic liver disease mortality rates
Manos, M. M., Leyden, W. A., Murphy, R. C., Terrault, N. A., & Bell, B. P. (2008) · Hepatology · doi:10.1002/hep.22181 · Cited by 96
Powell, L. W., & Kerr, J. F. R. (1970) · Australasian Annals of Medicine · doi:10.1111/imj.1970.19.1.54 · Cited by 96
Role of abnormal methionine metabolism in alcoholic liver injury
Lu, S. C.-L., Tsukamoto, H., & Mato, J. M. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00226-4 · Cited by 95
Sario, A. D., Bendia, E., Macarri, G., Candelaresi, C., Taffetani, S., Marzioni, M., Omenetti, A., Minicis, S. D., Trozzi, L., & Benedetti, A. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.05.012 · Cited by 93
Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis
Blumberg, R. S., Chopra, S., Ibrahim, R. E., Crawford, J. M., Farraye, F. A., Zeldis, J. B., & Berman, M. D. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90379-4 · Cited by 91
Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury
Douglass, A., Wallace, K., Parr, R., Park, J., Durward, E., Broadbent, I. D., Barelle, C. J., Porter, A. J., & Wright, M. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.032 · Cited by 90
A pilot study in patients with established advanced liver fibrosis using pirfenidone
Armendáriz‐Borunda, J., Islas-Carbajal, M. C., Meza-García, E., Rincón‐Sánchez, A. R., Lucano‐Landeros, S., Sandoval-Rodriguez, A. S., Salazar, A., Berumen-Campos, J., Álvarez-Rodríguez, A., Covarrubias, A., et al. (2006) · Gut · doi:10.1136/gut.2006.107136 · Cited by 89
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
Nabeshima, Y., Tazuma, S., Kanno, K., Hyogo, H., Iwai, M., Horiuchi, M., & Chayama, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.183 · Cited by 88
Spahr, L., Rubbia‐Brandt, L., Pugin, J., Giostra, E., Frossard, J., Borisch, B., & Hadengue, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00190-8 · Cited by 88
Kaplan, M. M., Cheng, S., Price, L. L., & Bonis, P. A. L. (2004) · Hepatology · doi:10.1002/hep.20103 · Cited by 87
Garcia-Bañuelos, J. J., Siller-López, F., Miranda, A., Aguilar, L. K., Aguilar-Córdova, E., & Armendáriz‐Borunda, J. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301647 · Cited by 87
Under-diagnosis of common chronic diseases: prevalence and impact on human health
Falagas, M. E., Vardakas, K. Z., & Vergidis, P. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01423.x · Cited by 82
Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin
Zhang, S., Ji, G., & Liu, J. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.09.002 · Cited by 82
Weng, H., Wang, B.-E., Jia, J., Wu, W., Xian, J.-Z., Mertens, P. R., Cai, W., & Dooley, S. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00404-0 · Cited by 81
Debernardi-Venon, W., Martini, S., Biasi, F., Vizio, B., Termine, A., Poli, G., Brunello, F., Alessandria, C., Bonardi, R., Saracco, G. M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.017 · Cited by 81
Pirfenidone Inhibits Dimethylnitrosamine‐Induced Hepatic Fibrosis In Rats
Tada, S., Nakamuta, M., Enjoji, M., Sugimoto, R., Iwamoto, H., Kato, M., Nakashima, Y., & Nawata, H. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03481.x · Cited by 79
Pirfenidone Inhibits Lung Allograft Fibrosis through L-Arginine–Arginase Pathway
Liu, H., Drew, P. A., Gaugler, A. C., Cheng, Y., & Visner, G. A. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00876.x · Cited by 78
Cited by
Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772
Evolving challenges in hepatic fibrosis
Friedman, S. L. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.97 · Cited by 581
Luo, P., Liu, D., Zhang, Q., Yang, F., Wong, Y.-K., Xia, F., Zhang, J., Chen, J., Tian, Y., Yang, C., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.007 · Cited by 377
Lee, Y., Kim, S. U., Song, K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B., & Han, K. (2016) · Hepatology · doi:10.1002/hep.28376 · Cited by 340
Lefebvre, E., Moyle, G., Reshef, R., Richman, L. P., Thompson, M., Hong, F., Chou, H.-L., Hashiguchi, T., Plato, C., Poulin, D., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158156 · Cited by 323
Metadata
- Authors
- Lim, Y.-S., & Kim, W. R.
- Venue
- Clinics in Liver Disease
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 12
- Issue
- 4
- Pages
- 733-746
- ISSN
- 1089-3261 (ISSN-L)
- OpenAlex
- W2159627633
- Cited by
- 316
- References
- 229
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.